Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

24432 ARTÍCULOS , VIENDO DEL 1951 AL 1965

Recent Advances in Therapeutics for the Treatment of Alzheimer's Disease

Thawabteh AM, Ghanem AW, AbuMadi S, Thaher D, Jaghama W, Karaman D, Karaman R.

Molecules. 2024 Oct 30;29(21):5131. doi: 10.3390/molecules29215131.

Dual inhibition of butyrylcholinesterase and p38α mitogen-activated protein kinase: A new approach for the treatment of Alzheimer's disease

Ferjančič Benetik S, Knez D, Obreza A, Košak U, Gobec S.

Pharmacol Ther. 2024 Dec;264:108748. doi: 10.1016/j.pharmthera.2024.108748. Epub 2024 Nov 7.

Insights on therapeutic approaches of natural anti-Alzheimer's agents in the management of Alzheimer's disease: A future perspective

Mahajan K, Sharma S, Gautam RK, Goyal R, Mishra DK, Singla RK.

J Alzheimers Dis. 2024 Dec;102(4):897-923. doi: 10.1177/13872877241296557. Epub 2024 Nov 10.

[The role and features of the gut microbiota in Alzheimer's disease.]

Tursumetova DR, Khan Y, Tkacheva LV, Rayevskii KP.

Adv Gerontol. 2024;37(4):442-452.

The phospho-tau cascade, basal forebrain neurodegeneration, and dementia in Alzheimer's disease: Anti-neurodegenerative benefits of acetylcholinesterase inhibitors

Moss DE, Perez RG.

J Alzheimers Dis. 2024 Dec;102(3):617-626. doi: 10.1177/13872877241289602. Epub 2024 Nov 12.

Approaches for studying neuroimmune interactions in Alzheimer's disease

Lin C', Tian Y, Tanzi RE, Jorfi M.

Trends Immunol. 2024 Dec;45(12):971-986. doi: 10.1016/j.it.2024.10.002. Epub 2024 Nov 12.

The impact of sex on memory during aging and Alzheimer's disease progression: Epigenetic mechanisms

Scheinman SB, Dong H.

J Alzheimers Dis. 2024 Dec;102(3):562-576. doi: 10.1177/13872877241288709. Epub 2024 Nov 14.

Non-canonical pathways associated to Amyloid beta and tau protein dyshomeostasis in Alzheimer's disease: A narrative review

Maggiore A, Latina V, D'Erme M, Amadoro G, Coccurello R.

Ageing Res Rev. 2024 Dec;102:102578. doi: 10.1016/j.arr.2024.102578. Epub 2024 Nov 13.

Dietary interventions in mitigating the impact of environmental pollutants on Alzheimer's disease - A review

Khandayataray P, Murthy MK.

Neuroscience. 2024 Dec 17;563:148-166. doi: 10.1016/j.neuroscience.2024.11.020. Epub 2024 Nov 13.

Acupuncture for patients with Alzheimer's disease: An evidence map of randomized controlled trials, systematic reviews, and meta-analysis

Ke C, Shan S, Yu J, Wei X, Pan J, Zhang W.

J Alzheimers Dis. 2024 Dec;102(4):924-942. doi: 10.1177/13872877241295400. Epub 2024 Nov 14.

Endothelial Dysfunctions in Blood-Brain Barrier Breakdown in Alzheimer's Disease: From Mechanisms to Potential Therapies

Yue Q, Leng X, Xie N, Zhang Z, Yang D, Hoi MPM.

CNS Neurosci Ther. 2024 Nov;30(11):e70079. doi: 10.1111/cns.70079.

Passive anti-amyloid β immunotherapy in Alzheimer's disease-opportunities and challenges

Heneka MT, Morgan D, Jessen F.

Lancet. 2024 Nov 30;404(10468):2198-2208. doi: 10.1016/S0140-6736(24)01883-X. Epub 2024 Nov 14.

[Research progress of mechanism of acupuncture and moxibustion on prevention and treatment of Alzheimer's disease based on the neuronal cell cycle re-entry]

Luo YY, Shan XQ, Song JJ, Hao N, Zhao L.

Zhen Ci Yan Jiu. 2024 Nov 25;49(11):1205-1212. doi: 10.13702/j.1000-0607.20230547.

Phase 1 Studies of the Anti-Tau Monoclonal Antibody JNJ-63733657 in Healthy Participants and Participants with Alzheimer's Disease

Galpern WR, Triana-Baltzer G, Li L, Van Kolen K, Timmers M, Haeverans K, Janssens L, Kolb H, Nandy P, Aida K, Shimizu H, Mercken M, Sun H.

J Prev Alzheimers Dis. 2024;11(6):1592-1603. doi: 10.14283/jpad.2024.163.

Roles of TREM2 in the Pathological Mechanism and the Therapeutic Strategies of Alzheimer's Disease

Lin M, Yu JX, Zhang WX, Lao FX, Huang HC.

J Prev Alzheimers Dis. 2024;11(6):1682-1695. doi: 10.14283/jpad.2024.164.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias